Anti-SSA/Ro antibodies and the heart: More than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options

Arthritis Research and Therapy

Volumn 7, Issue 2, 2005, Pages 69-73

  Costedoat Chalumeau, Nathalie ^a   Amoura, Zahir ^a   Villain, Elisabeth ^b   Cohen, Laurence ^c   Piette, Jean Charles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Institut Jacques Cartier   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; FLUORINATED STEROID; RO ANTIBODY;

CARDIOMYOPATHY; CLINICAL FEATURE; CLINICAL TRIAL; COMPLETE HEART BLOCK; CONGENITAL HEART BLOCK; CONGENITAL HEART MALFORMATION; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; ENDOCARDIAL FIBROELASTOSIS; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; MEDICAL DECISION MAKING; MYOCARDIAL DISEASE; NONHUMAN; PATHOGENESIS; PRENATAL CARE; QT PROLONGATION; REVIEW; RISK BENEFIT ANALYSIS; SINUS BRADYCARDIA; TREATMENT PLANNING;

ADULT; AGE OF ONSET; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; BETAMETHASONE; BRADYCARDIA; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; DEXAMETHASONE; ELECTROCARDIOGRAPHY; ENDOCARDIAL FIBROELASTOSIS; FEMALE; FETAL HEART; HEART BLOCK; HEART DEFECTS, CONGENITAL; HEART DISEASES; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT; INFANT, NEWBORN; LONG QT SYNDROME; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MULTICENTER STUDIES; MYOCARDIUM; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 15944397264     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar1690     Document Type: Review

References (35)

1. Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren-Herlenius M: Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies Arthritis Rheum 2004, 50:1253-1261.
2. Cimaz R, Stramba-Badiale M, Brucato A, Catelli L, Panzeri P, Meroni PL: QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. Arthritis Rheum 2000, 43:1049-1053.
3. Gordon PA, Khamashta MA, Hughes GR, Rosenthal E: Increase in the heart rate-corrected QT interval in children of anti-Ro-positive mothers, with a further increase in those with siblings with congenital heart block: comment on the article by Cimaz et al. Arthritis Rheum 2001, 44:242-243.
4. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, Muscara M, Vignati G, Stramba-Badiale M, Catelli L, et al.: Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterim-munoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001, 44: 832-1835.
5. Moak JP, Barron KS, Hougen TJ, Wiles HB, Balaji S, Sreeram N, Cohen MH, Nordenberg A, Van Hare GF, Friedman RA, et al.: Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001, 37:238-242.
6. Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen JB, Silverman NH, Finley JP, Law YM, Human DG, Seaward PG, et al.: Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 2002, 105:843-848.
7. Nield LE, Silverman ED, Smallhorn JF, Taylor GP, Mullen JB, Benson LN, Hornberger LK: Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol 2002, 40: 796-802.
8. Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM, Thi Huong du L, Denjoy I, Vauthier D, Sebbouh D, Fain O, Georgin-Lavialle S, Ghillani P, et al.: Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum 2004, 50: 3187-3194.
9. Lazzerini PE, Acampa M, Guideri F, Capecchi PL, Campanella V, Morozzi G, Galeazzi M, Marcolongo R, Laghi-Pasini F: Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Arthritis Rheum 2004, 50: 248-1252.
10. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, Lee LA, Provost TT, Reichlin M, Rider L, et al.: Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998, 31:1658-1666.
11. Eronen M, Siren MK, Ekblad H, Tikanoja T, Julkunen H, Paavilainen T: Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000, 106:86-91.
12. Brucato A, Gasparini M, Vignati G, Riccobono S, De Juli E, Quinzanini M, Bortolon C, Coluccio E, Massari D: Isolated congenital complete heart block: longterm outcome of children and immunogenetic study. J Rheumatol 1995, 22:541-543.
13. Askanase AD, Friedman DM, Copel J, Dische MR, Dubin A, Starc TJ, Katholi MC, Buyon JP: Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies. Lupus 2002, 11:145-151.
14. Glickstein JS, Buyon J, Friedman D: Pulsed Doppler echocardiographic assessment of the fetal PR interval. Am J Cardiol 2000, 86:236-239.
15. Glickstein J, Buyon J, Kim M, Friedman D: The fetal Doppler mechanical PR interval: a validation study. Fetal Diagn Ther 2004, 19:31-34.
16. Andelfinger G, Fouron JC, Sonesson SE, Proulx F: Reference values for time intervals between atrial and ventricular contractions of the fetal heart measured by two Doppler techniques. Am J Cardiol 2001, 88:1433-1436, A1438.
17. Friedman D, Buyon J, Copel J, Kim M: PR interval and dexamethasone evaluation: an ongoing prospective fetal echocardiographic study in neonatal lupus. I - observational. [Abstract]. Lupus 2004, 13:760.
18. Cimaz R, Meroni PL, Brucato A, Fesstova VV, Panzeri P, Goulene K, Stramba-Badiale M: Concomitant disappearance of electro-cardiographic abnormalities and of acquired maternal autoantibodies during the first year of life in infants who had QT interval prolongation and anti-SSA/Ro positivity without congenital heart block at birth. Arthritis Rheum 2003, 48:266-268.
19. Schwartz PJ, Montemerlo M, Facchini M, Salice P, Rosti D, Poggio G, Giorgetti R: The QT interval throughout the first 6 months of life: a prospective study. Circulation 1982, 66: 96-501.
20. Gordon PA, Rosenthal E, Khamashta MA, Hughes GR: Absence of conduction defects in the electrocardiograms of mothers with children with congenital complete heart block. J Rheumatol 2001, 28: 66-369.
21. Costedoat-Chalumeau N, Amoura Z, Hulot JS, Ghillani P, Funck-Brentano C, Lechat P, Piette JC: Letter in response to 'Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases' by Lazzerini et al. in Arthritis Rheum 2004, 50:1248-1252. Arthritis Rheum 2005, in press.
22. Menon A, Silverman ED, Gow RM, Hamilton RM: Chronotropic competence of the sinus node in congenital complete heart block. Am J Cardiol 1998, 82:1119-1121.
23. Mazel JA, El-Sherif N, Buyon J, Boutjdir M: Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block. Circulation 1999, 99:1914-1918.
24. Hu K, Qu Y, Yue Y, Boutjdir M: Functional basis of sinus bradycardia in congenital heart block. Circ Res 2004, 94: 32-e38.
25. Southall DP, Richards J, Brown DJ, Johnston PG, de Swiet M, Shinebourne EA: 24-hour tape recordings of ECG and respiration in the newborn infant with findings related to sudden death and unexplained brain damage in infancy. Arch Dis Child 1980, 55:7-16.
26. Hogg GR: Congenital, acute lupus erythematosus associated with subendocardial fibroelastosis. Report of a case. Am J Clin Pathol 1957, 28:648-654.
27. Report 8: Surveillance of Congenital Anomalies in Europe 1980-1999 [www.eurocat.ulster.ac.uk/pubdata/report8tab.html]. Accessed April 2003.
28. Saleeb S, Copel J, Friedman D, Buyon JP: Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999, 42:2335-2345.
29. Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK: Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 2004, 110: 1542-1548.
30. Buyon JP, Rupel A, Clancy RM: Neonatal lupus syndromes. Lupus 2004, 13:705-712.
31. Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E, Huon C, Lepercq J, Dehan M, Lacaze-Masmonteil T: Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999, 341:1190-1196.
32. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, Wechsler B, Vauthier D, Ghillani P, Papo T, Fain O, Musset L, Piette JC: Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 2003, 62: 1010-1012.
33. Chico A, Manzanares JM, Halperin I, Martinez de Osaba MJ, Adelantado J, Webb SM: Cushing's disease and pregnancy: report of six cases. Eur J Obstet Gynecol Reprod Biol 1996, 64:143-146.
34. Buyon JP, Clancy RM: Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach. Semin Arthritis Rheum 2003, 33:140-154.
35. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, Georgin S, Vauthier D, Sebbouh D, Frances C, Villain E, Wechsler B, Piette JC: Neonatal lupus syndrome: review of the literature. [In French]. Rev Med Interne 2003, 24:659-671.